Affiliation:
1. Centers for Disease Control and Prevention, 4770 Buford Highway NE, Chamblee, GA 30341, USA
Abstract
Background: The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention assesses the adherence to established performance standards of manufactured lots of whole blood filter paper collection devices that are registered by the US FDA. We examined 26 newborn screening analytes measured from blood applied to filter papers from two FDA-cleared sources, Whatman® Grade 903 and Ahlstrom Grade 226. The dried blood spots contained analytes at both single levels and dose–response series. Results: We observed overlap at one standard deviation for each analyte, with no more than 4–5% difference between the papers. Conclusion: The data demonstrated similarities of analyte recovery between the papers, indicating comparability of the devices for newborn screening and other applications.
Subject
Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献